Content deleted Content added
Ian.morison (talk | contribs) No edit summary |
m MOS:UNITSYMBOLS (via WP:JWB) |
||
Line 341:
|
|0.03<ref name=Mangla/>
|ng/
|99th percentile [[cutoff (reference value)|cutoff]]
|-
Line 399:
|rowspan=6| [[Triglyceride]]s ||rowspan=2| 10–39 years || 54<ref name=bloodbook/> || 110<ref name=bloodbook/> || mg/dL ||rowspan=6| < 100 mg/dL<ref name=adeeva/> <br /> or 1.1 mmol/L<ref name=adeeva/>
|-
| 0.61<ref name=tg-mass>Derived from values in mg/
|-
|rowspan=2| 40–59 years || 70<ref name=bloodbook/> || 150<ref name=bloodbook/> || mg/dL
Line 409:
| 0.9<ref name=tg-mass/> || 1.7<ref name=tg-mass/> || mmol/L
|-
|rowspan=2| Total [[cholesterol]] ||rowspan=2| || 3.0,<ref name=ch-mass>Derived from values in mg/
|-
| 120,<ref name=southwest/> 140<ref name=firstaid/> || 200,<ref name=southwest/> 250<ref name=firstaid/> || mg/dL || < 150 mg/dL<ref name=adeeva/>
Line 415:
|rowspan=2| [[HDL cholesterol]] ||rowspan=2| Female || 1.0,<ref name=rcpa>[http://www.rcpamanual.edu.au/sections/pathologytest.asp?s=33&i=450 Royal College of Pathologists of Australasia; Cholesterol (HDL and LDL) – plasma or serum] Last Updated: Monday, 6 August 2007</ref> 1.2,<ref name=uppsala/> 1.3<ref name=ch-mass/> || 2.2<ref name=rcpa/> || mmol/L ||rowspan=4| > 1.0<ref name=rcpa/> or 1.6<ref name=ch-mass/> mmol/L <br /> 40<ref name=ch-molar/> or 60<ref>[http://www.americanheart.org/presenter.jhtml?identifier=183 What Your Cholesterol Levels Mean.] American Heart Association. Retrieved on September 12, 2009</ref> mg/dL
|-
| 40,<ref name=ch-molar>Derived from values in mmol/
|-
|rowspan=2| HDL cholesterol ||rowspan=2| Male || 0.9<ref name=uppsala/><ref name=rcpa/> || 2.0<ref name=rcpa/> || mmol/L
Line 440:
| [[Alpha fetoprotein]] (AFP) || || 44<ref name=southwest/> || ng/mL or µg/L || Hepatocellular carcinoma or testicular cancer
|-
| Beta [[human chorionic gonadotrophin]] (β-hCG) || In males and non-pregnant females || 5<ref name=southwest/> || IU/
|-
| [[CA19-9]] || || 40<ref name=southwest/> || U/mL || Pancreatic cancer
Line 550:
|rowspan=4| [[17α-Hydroxyprogesterone]] ||rowspan=2| male || 0.06<ref name=bloodbook/> || 3.0<ref name=bloodbook/> || mg/L
|-
| 0.18<ref name=17hpg-mass>Derived from mass values using molar mass of 330.46g/mol</ref> || 9.1<ref name=17hpg-mass/> || µmol/
|-
|rowspan=2| Female (Follicular phase) || 0.2<ref name=bloodbook/> || 1.0<ref name=bloodbook/> || mg/L
|-
| 0.6<ref name=17hpg-mass/> || 3.0<ref name=17hpg-mass/> || µmol/
|-
|rowspan=6| [[Follicle-stimulating hormone|Follicle-stimulating<br /> hormone]] (FSH)<br />{{hatnote|-more detailed menstrual cycle<br /> ranges in [[:File:Follicle-stimulating hormone (FSH) during menstrual cycle.png|separate diagram]]}} || Prepubertal || <1<ref name=gpnotebook-FSH>[http://www.gpnotebook.co.uk/simplepage.cfm?ID=436600899 reference range (FSH)] GPnotebook. Retrieved on September 27, 2009</ref> || 3<ref name=gpnotebook-FSH/> ||rowspan=6| IU/L
Line 610:
|-
| 5<ref name=amh-mass>Derived from mass values using 140,000 g/mol, as given in:
* {{cite journal |vauthors=Hampl R, Šnajderová M, Mardešić T |title=Antimüllerian hormone (AMH) not only a marker for prediction of ovarian reserve |journal=Physiological Research |volume=60 |issue=2 |pages=217–23 |year=2011 |pmid=21114374 |doi=10.33549/physiolres.932076 |doi-access=free }}</ref> || 140<ref name=amh-mass/> || pmol/
|}
Line 679:
| || 530,<ref name=aldosterone-mass/> 940<ref name=aldosterone-mass>Converted from mass values using molar mass of 360.44 g/mol</ref> || pmol/L
|-
|rowspan=2| [[Aldosterone-to-renin ratio]] <br />{{hatnote|-more detailed ranges in <br />[[Aldosterone-to-renin ratio|Aldosterone/renin ratio]] article}} ||rowspan=2| Adult || || 13.1,<ref name=Tiu2004/> 35.0<ref name=Tiu2004>{{cite journal |vauthors=Tiu SC, Choi CH, Shek CC, etal |title=The use of aldosterone-renin ratio as a diagnostic test for primary hyperaldosteronism and its test characteristics under different conditions of blood sampling |journal=The Journal of Clinical Endocrinology and Metabolism |volume=90 |issue=1 |pages=72–78 |date=January 2005 |pmid=15483077 |doi=10.1210/jc.2004-1149|citeseerx=10.1.1.117.5182 }}</ref> || ng/
|-
| || 360,<ref name=Tiu2004/> 970<ref name=Tiu2004/> || pmol/liter per µg/(L·h)
Line 805:
| || 31,<ref name=southwest/> 32<ref name=uppsala/><ref name=bloodbook/> || 35,<ref name=southwest/> 36<ref name=uppsala/><ref name=bloodbook/> || g/dL or %<ref name="MCHC" group="note"/>
|-
|rowspan=3| Erythrocytes/[[Red blood cells]] (RBC) || Male || 4.2,<ref name=bloodbook/> 4.3<ref name=uppsala/><ref name=firstaid/><ref name=southwest/> || 5.7,<ref name=uppsala/> 5.9,<ref name=firstaid/> 6.2,<ref name=southwest/> 6.9<ref name=bloodbook/> ||rowspan=3| x10<sup>12</sup>/L<br />or<br />[[million
|-
| Female || 3.5,<ref name=firstaid/> 3.8,<ref name=southwest/> 3.9<ref name=uppsala/> || 5.1,<ref name=uppsala/> 5.5<ref name=firstaid/><ref name=southwest/> ||
Line 1,146:
| 0.6<ref name=Dart/> || 2.6<ref name=Dart/> || nmol/L
|-
| [[Lithium (medication)|Lithium]] || 0.4,<ref>The UK Electronic Medical Compendium recommends 0.4–0.8 mmol/
| last1 = Solomon | first1 = D.
| last2 = Ristow | first2 = W.
Line 1,161:
| year = 1996
| pmid = 8831438 | doi=10.1176/ajp.153.10.1301
}}) concluded a "low" dose of 0.4–0.6 mmol/L serum lithium treatment for patients with bipolar 1 disorder had less side effects, but a higher rate of relapse, than a "standard" dose of 0.8–1.0 mmol/
| last1 = Perlis | first1 = R.
| last2 = Sachs | first2 = G.
| |||